We are live on ! Find out more
NRG

Nemes Rush Group Portfolio holdings

AUM $1.05B
1-Year Est. Return 30.08%
This Fund
S&P 500
This Quarter Est. Return
+12.92%
1 Year Est. Return
+30.08%
3 Year Est. Return
+95.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$620M
AUM Growth
+$68.5M
Cap. Flow
+$3.92M
Cap. Flow %
0.63%
Top 10 Hldgs %
33.29%
Holding
704
New
45
Increased
129
Reduced
154
Closed
42

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.84M
2
AMD icon
Advanced Micro Devices
AMD
+$4.01M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$735K
4
LHX icon
L3Harris
LHX
+$291K
5
IBB icon
iShares Biotechnology ETF
IBB
+$289K

Top Sells

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$4.26M
2
EL icon
Estee Lauder
EL
+$3.72M
3
AAPL icon
Apple
AAPL
+$827K
4
JNJ icon
Johnson & Johnson
JNJ
+$619K
5
AVGO icon
Broadcom
AVGO
+$611K

Sector Composition

Rank Sector Weight
1 Technology 32.03%
2 Financials 14.71%
3 Healthcare 11.3%
4 Consumer Discretionary 10.98%
5 Industrials 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IR icon
251
Ingersoll Rand
IR
$33.9B
$55.7K 0.01%
720
– –
WY icon
252
Weyerhaeuser
WY
$17.7B
$55.6K 0.01%
1,600
– –
SHEL icon
253
Shell
SHEL
$238B
$53.1K 0.01%
807
– –
WDAY icon
254
Workday
WDAY
$39.4B
$51.9K 0.01%
188
– –
FTNT icon
255
Fortinet
FTNT
$110B
$51.3K 0.01%
877
-35
-4% -$1.93K
MFC icon
256
Manulife Financial
MFC
$74.2B
$50.7K 0.01%
2,294
– –
STEW
257
SRH Total Return Fund
STEW
$1.79B
$50.1K 0.01%
+3,609
New +$47.5K
CP icon
258
Canadian Pacific Kansas City
CP
$81.4B
$49.3K 0.01%
624
– –
GIS icon
259
General Mills
GIS
$20.1B
$49K 0.01%
752
– –
NVO
260
Novo Nordisk
NVO
$225B
$47.2K 0.01%
456
+27
+6% +$2.67K
NVS icon
261
Novartis
NVS
$304B
$47.1K 0.01%
466
– –
FVD icon
262
First Trust Value Line Dividend Fund
FVD
$8.46B
$46.2K 0.01%
1,140
– –
BKR icon
263
Baker Hughes
BKR
$58B
$45.7K 0.01%
1,338
+4
+0.3% +$136
INMD icon
264
InMode
INMD
$889M
$45.1K 0.01%
2,029
-1,378
-40% -$30.9K
IYC icon
265
iShares US Consumer Discretionary ETF
IYC
$1.16B
$44.9K 0.01%
+593
New +$41.4K
PYPL icon
266
PayPal
PYPL
$50.3B
$44.8K 0.01%
729
-456
-38% -$26.1K
GSK icon
267
GSK
GSK
$108B
$44.5K 0.01%
1,201
– –
CLX icon
268
Clorox
CLX
$12.1B
$44.5K 0.01%
312
+13
+4% +$1.73K
OC icon
269
Owens Corning
OC
$11.5B
$44.5K 0.01%
300
-23
-7% -$3.05K
BSX icon
270
Boston Scientific
BSX
$68.5B
$44.3K 0.01%
767
– –
COP icon
271
ConocoPhillips
COP
$139B
$44.2K 0.01%
380
– –
TPSC icon
272
Timothy Plan US Small Cap Core ETF
TPSC
$364M
$43.9K 0.01%
1,240
– –
MRSH
273
Marsh
MRSH
$91.7B
$43.8K 0.01%
231
– –
TPLC icon
274
Timothy Plan US Large/Mid Cap Core ETF
TPLC
$310M
$43.8K 0.01%
1,145
– –
HNRG icon
275
Hallador Energy
HNRG
$689M
$43.6K 0.01%
4,930
-550
-10% -$6.94K
9 10
11
12 13

Similar funds

HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
SPC
Spirepoint Private Client Vero Beach, Florida $1.05B AUM 22.43% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
KA
Kintegral Advisory New York $1.06B AUM 24.93% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Nemes Rush Group's Q4 2023 Portfolio in Review

As of Q4 2023, Nemes Rush Group held 704 positions worth $620M, up 12% from $552M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Nemes Rush Group's Q4 2023 filing shows 45 new, 129 increased, 154 reduced and 42 closed positions. Its largest new stake was iShares Biotechnology ETF: 2,367 shares worth $322K. The largest sale was Keysight, an estimated $4.26M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • Nemes Rush Group's largest Q4 2023 buy was iShares Biotechnology ETF: 2,367 shares worth $322K.
  • Nemes Rush Group added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $6.84M increase.
  • Nemes Rush Group's biggest Q4 2023 reduction was Keysight, cutting an estimated $4.26M.
  • Nemes Rush Group fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $109K.
  • Nemes Rush Group's ten largest holdings make up 33% of its $620M portfolio in Q4 2023.
  • Nemes Rush Group opened 45 new positions and closed 42 in Q4 2023.
  • Nemes Rush Group's portfolio value rose 12% quarter-over-quarter to $620M.

Based on Nemes Rush Group's 13F filing for Q4 2023, filed 9 Feb 2024.